Management Thalassemia in Indonesia : A Literature Review

Friska Kamila Nabilasefanty; Pradana Zaky Romadhon

doi:10.62951/ijhm.v2i1.214

Authors

Friska Kamila Nabilasefanty Universitas Airlangga
Pradana Zaky Romadhon Universitas Airlangga

DOI:

https://doi.org/10.62951/ijhm.v2i1.214

Keywords:

Thalassemia, Management, Treatment, Indonesia

Abstract

Thalassemia is a disease classified in the group of hereditary hemolytic anemia caused by the failure of the formation of one of the four amino acid chains forming Hb, causing incomplete Hb formation. Thalassemia carriers account for 7% of the world's population. At present, the cornerstone of treatment for β-TM in Indonesia remains supportive, including blood transfusions and iron chelation therapy. With a comprehensive discussion about thalassemia in Indonesia, it is hoped that the diagnosis and treatment of thalassemia will be more optimal and effective in future research.

Downloads

Download data is not yet available.

References

Bajwa, et al. (2023). Thalassemia. StatPearls Publishing.

Cousens, N. E., et al. (2010). Carrier screening for beta-thalassaemia: a review of international practice. European journal of human genetics : EJHG, 18(10). https://doi.org/10.1038/ejhg.2010.90

De Sanctis, et al. (2017). β-thalassemia Distribution in the Old World: an Ancient Disease Seen from a Historical Standpoint. Mediterr. J. Hematol. Infect. Dis. (Informasi penerbit dan halaman diperlukan untuk format APA lengkap)

Indonesia, Ministry of Health. (2018). National Guidelines for Thalassemia Management Medical Services. Indonesia: MHRI.

Indonesia, Ministry of Health. (2021). Indonesia Health Profile 2021. Retrieved from https://www.globalhep.org/ (Halaman spesifik diperlukan untuk format APA lengkap)

Jaing, et al. (2021). Molecular genetics of β-thalassemia: A narrative review. Medicine (Baltimore), 100(45). doi: 10.1097/MD.0000000000027522

Khan, I., et al. (2024). Beta Thalassemia Major (Cooley Anemia). StatPearls. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK557522/

Nemeth, E. (2010). Hepcidin in beta-thalassemia. Ann N Y Acad Sci, 1192, 31-35. https://doi.org/10.1111/j.1749-6632.2010.05585.x

Rahayu, et al. (2016). Dukungan Keluarga dalam Kepatuhan Terapi pada Pasien Thalasemia di Rumah Sakit Umum Daerah Kabupaten Ciamis Tahun 2015. Mutiara Medika, 16(2).

Wahidiyat, P. A., et al. (2022). Thalassemia in Indonesia. Hemoglobin, 46(1), 39–44. https://doi.org/10.1080/03630269.2021.2023565